Abstract:Charged-particle radiotherapy (CPRT) utilizing low and high linear energy transfer (low-/high-LET) ionizing radiation (IR) is a promising cancer treatment modality having unique physical energy deposition properties. CPRT enables focused delivery of a desired dose to the tumor, thus achieving a better tumor control and reduced normal tissue toxicity. It increases the overall radiation tolerance and the chances of survival for the patient. Further improvements in CPRT are expected from a better understanding of… Show more
“…DNA damage, especially DSB, rapidly induces the DNA damage response (DDR) pathway [ 133 , 142 ]. The primary pathways of DBS DNA repair are homologous recombination repair (HRR), non-homologous end-joining (NHEJ), and alternative end-joining (alt-EJ) [ 133 , 142 , 143 , 144 ]. These three pathways involve different initiating proteins that recognize DSB and different downstream enzymes ( Table 4 ).…”
Section: Signal Transduction By High and Low Letmentioning
Exposure to ionizing radiation can occur during medical treatments, from naturally occurring sources in the environment, or as the result of a nuclear accident or thermonuclear war. The severity of cellular damage from ionizing radiation exposure is dependent upon a number of factors including the absorbed radiation dose of the exposure (energy absorbed per unit mass of the exposure), dose rate, area and volume of tissue exposed, type of radiation (e.g., X-rays, high-energy gamma rays, protons, or neutrons) and linear energy transfer. While the dose, the dose rate, and dose distribution in tissue are aspects of a radiation exposure that can be varied experimentally or in medical treatments, the LET and eV are inherent characteristics of the type of radiation. High-LET radiation deposits a higher concentration of energy in a shorter distance when traversing tissue compared with low-LET radiation. The different biological effects of high and low LET with similar energies have been documented in vivo in animal models and in cultured cells. High-LET results in intense macromolecular damage and more cell death. Findings indicate that while both low- and high-LET radiation activate non-homologous end-joining DNA repair activity, efficient repair of high-LET radiation requires the homologous recombination repair pathway. Low- and high-LET radiation activate p53 transcription factor activity in most cells, but high LET activates NF-kB transcription factor at lower radiation doses than low-LET radiation. Here we review the development, uses, and current understanding of the cellular effects of low- and high-LET radiation exposure.
“…DNA damage, especially DSB, rapidly induces the DNA damage response (DDR) pathway [ 133 , 142 ]. The primary pathways of DBS DNA repair are homologous recombination repair (HRR), non-homologous end-joining (NHEJ), and alternative end-joining (alt-EJ) [ 133 , 142 , 143 , 144 ]. These three pathways involve different initiating proteins that recognize DSB and different downstream enzymes ( Table 4 ).…”
Section: Signal Transduction By High and Low Letmentioning
Exposure to ionizing radiation can occur during medical treatments, from naturally occurring sources in the environment, or as the result of a nuclear accident or thermonuclear war. The severity of cellular damage from ionizing radiation exposure is dependent upon a number of factors including the absorbed radiation dose of the exposure (energy absorbed per unit mass of the exposure), dose rate, area and volume of tissue exposed, type of radiation (e.g., X-rays, high-energy gamma rays, protons, or neutrons) and linear energy transfer. While the dose, the dose rate, and dose distribution in tissue are aspects of a radiation exposure that can be varied experimentally or in medical treatments, the LET and eV are inherent characteristics of the type of radiation. High-LET radiation deposits a higher concentration of energy in a shorter distance when traversing tissue compared with low-LET radiation. The different biological effects of high and low LET with similar energies have been documented in vivo in animal models and in cultured cells. High-LET results in intense macromolecular damage and more cell death. Findings indicate that while both low- and high-LET radiation activate non-homologous end-joining DNA repair activity, efficient repair of high-LET radiation requires the homologous recombination repair pathway. Low- and high-LET radiation activate p53 transcription factor activity in most cells, but high LET activates NF-kB transcription factor at lower radiation doses than low-LET radiation. Here we review the development, uses, and current understanding of the cellular effects of low- and high-LET radiation exposure.
“…Alt-EJ operates with slower kinetics and lower efficiency than c-NHEJ, and is error-prone causing deletions and other modifications at the junction, more than c-NHEJ. Alt-EJ also can join unrelated DNA-ends and is therefore considered a dominant source of SCAs ( Zhang et al, 2010 ; Soni et al, 2015 ; Mladenova et al, 2022 ). Single-strand annealing (SSA) is also error-prone owing to the large deletions it generates between the homologous DNA segments it requires for normal function, and can be promiscuous in partner selection and form SCAs ( Bhargava et al, 2016 ; Iliakis et al, 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…HR, alt-EJ and SSA are classified as DNA end-resection resection (henceforth simply resection) -dependent DSB-repair pathways, because they share this initial processing step ( Ceccaldi et al, 2016 ). During this step, the MRN/CtIP complex orchestrates short-range resection that is followed by BLM-DNA2/EXO1-mediated long-range resection ( Sartori et al, 2007 ; Mladenova et al, 2022 ). The resulting ssDNA is a prerequisite for the engagement of HR and SSA, and benefits also alt-EJ ( Paiano et al, 2021 ) by exposing microhomologies (4-6bp).…”
Heavy-ion radiotherapy utilizing high linear energy transfer (high-LET) ionizing radiation (IR) is a promising cancer treatment modality owing to advantageous physical properties of energy deposition and associated toxicity over X-rays. Therapies utilizing high-LET radiation will benefit from a better understanding of the molecular mechanisms underpinning their increased biological efficacy. Towards this goal, we investigate here the biological consequences of well-defined clusters of DNA double-strand breaks (DSBs), a form of DNA damage, which on theoretical counts, has often been considered central to the enhanced toxicity of high-LET IR. We test clonal cell lines harboring in their genomes constructs with appropriately engineered I-SceI recognition sites that convert upon I-SceI expression to individual DSBs, or DSB-clusters comprising known numbers of DSBs with defined DNA-ends. We find that, similarly to high-LET IR, DSB-clusters of increasing complexity, i.e. increasing numbers of DSBs, with compatible or incompatible ends, compromise classical non-homologous end-joining, favor DNA end-resection and promote resection-dependent DSB-processing. Analysis of RAD51 foci shows increased engagement of error-free homologous recombination on DSB-clusters. Multicolor fluorescence in situ hybridization analysis shows that complex DSB-clusters markedly increase the incidence of structural chromosomal abnormalities (SCAs). Since RAD51-knockdown further increases SCAs-incidence, we conclude that homologous recombination suppresses SCAs-formation. Strikingly, CtIP-depletion inhibits SCAs-formation, suggesting that it relies on alternative end-joining or single-strand annealing. Indeed, ablation of RAD52 causes a marked reduction in SCAs, as does also inhibition of PARP1. We conclude that increased DSB-cluster formation that accompanies LET-increases, enhances IR-effectiveness by promoting DNA end-resection, which suppresses c-NHEJ and enhances utilization of alt-EJ or SSA. Although increased resection also favors HR, on balance, error-prone processing dominates, causing the generally observed increased toxicity of high-LET radiation. These findings offer new mechanistic insights into high-LET IR-toxicity and have translational potential in the clinical setting that may be harnessed by combining high-LET IR with inhibitors of PARP1 or RAD52.
“…These kinases enable the activation and recruitment of BRCA1, PALB2 and BRCA2 that exchange RPA with recombinase RAD51, a key protein of HRR that forms a nucleoprotein filament [ 12 ]. Several RAD51 paralogs, including XRCC3, facilitate this process [ 13 ]. Then, the RAD51 nucleoprotein filament searches for a homologous template in the sister chromatid, leading to strand invasion and elongation.…”
Section: Introductionmentioning
confidence: 99%
“…Then, the RAD51 nucleoprotein filament searches for a homologous template in the sister chromatid, leading to strand invasion and elongation. This results in the formation of Holliday junction intermediates, which can be resolved differently, resulting in completely repaired DSBs [ 13 ].…”
Radiotherapy (RT) for breast cancer significantly impacts patient survival and causes adverse events. Double-strand breaks are the most harmful type of DNA damage associated with RT, which is repaired through homologous recombination (HRR). As genetic variability of DNA repair genes could affect response to RT, we aimed to evaluate the association of polymorphisms in HRR genes with tumor characteristics and the occurrence of RT adverse events in early HER2-positive breast cancer. Our study included 101 breast cancer patients treated with adjuvant RT and trastuzumab. All patients were genotyped for eight single nucleotide polymorphisms in NBN, RAD51 and XRCC3 using competitive allele-specific PCR. Carriers of XRCC3 rs1799794 GG genotype were less likely to have higher tumor differentiation grade (OR = 0.05, 95% CI = 0.01â0.44, p = 0.007). Carriers of RAD51 rs1801321 TT genotype were more likely to have higher NYHA class in univariable (OR = 10.0; 95% CI = 1.63â61.33; p = 0.013) and multivariable (OR = 9.27; 95% CI = 1.28â67.02; p = 0.027) analysis. Carriers of RAD51 rs12593359 GG genotype were less likely to have higher NYHA class in univariable (OR = 0.09; 95% CI = 0.01â0.79; p = 0.030) and multivariable (OR = 0.07; 95% CI = 0.01â0.81; p = 0.034) analysis. Carriers of XRCC3 rs1799794 GG genotypes experienced more skin adverse events based on LENT-SOMA scale in univariable (OR = 5.83; 95% CI = 1.22â28.00; p = 0.028) and multivariable (OR = 10.90; 95% CI = 1.61â73.72; p = 0.014) analysis. In conclusion, XRCC3 and RAD51 polymorphisms might contribute to RT adverse events in early HER2-positive breast cancer patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.